Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 204

1.

Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease.

Malek-Ahmadi M, Beach TG, Zamrini E, Adler CH, Sabbagh MN, Shill HA, Jacobson SA, Belden CM, Caselli RJ, Woodruff BK, Rapscak SZ, Ahern GL, Shi J, Caviness JN, Driver-Dunckley E, Mehta SH, Shprecher DR, Spann BM, Tariot P, Davis KJ, Long KE, Nicholson LR, Intorcia A, Glass MJ, Walker JE, Callan M, Curry J, Cutler B, Oliver J, Arce R, Walker DG, Lue LF, Serrano GE, Sue LI, Chen K, Reiman EM.

PLoS One. 2019 Jun 25;14(6):e0217566. doi: 10.1371/journal.pone.0217566. eCollection 2019.

2.

Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age.

Wingo AP, Dammer EB, Breen MS, Logsdon BA, Duong DM, Troncosco JC, Thambisetty M, Beach TG, Serrano GE, Reiman EM, Caselli RJ, Lah JJ, Seyfried NT, Levey AI, Wingo TS.

Nat Commun. 2019 Apr 8;10(1):1619. doi: 10.1038/s41467-019-09613-z.

3.

Applying surface-based hippocampal morphometry to study APOE-E4 allele dose effects in cognitively unimpaired subjects.

Dong Q, Zhang W, Wu J, Li B, Schron EH, McMahon T, Shi J, Gutman BA, Chen K, Baxter LC, Thompson PM, Reiman EM, Caselli RJ, Wang Y.

Neuroimage Clin. 2019;22:101744. doi: 10.1016/j.nicl.2019.101744. Epub 2019 Mar 4.

4.

Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD.

Pottier C, Ren Y, Perkerson RB 3rd, Baker M, Jenkins GD, van Blitterswijk M, DeJesus-Hernandez M, van Rooij JGJ, Murray ME, Christopher E, McDonnell SK, Fogarty Z, Batzler A, Tian S, Vicente CT, Matchett B, Karydas AM, Hsiung GR, Seelaar H, Mol MO, Finger EC, Graff C, Öijerstedt L, Neumann M, Heutink P, Synofzik M, Wilke C, Prudlo J, Rizzu P, Simon-Sanchez J, Edbauer D, Roeber S, Diehl-Schmid J, Evers BM, King A, Mesulam MM, Weintraub S, Geula C, Bieniek KF, Petrucelli L, Ahern GL, Reiman EM, Woodruff BK, Caselli RJ, Huey ED, Farlow MR, Grafman J, Mead S, Grinberg LT, Spina S, Grossman M, Irwin DJ, Lee EB, Suh E, Snowden J, Mann D, Ertekin-Taner N, Uitti RJ, Wszolek ZK, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Hodges JR, Piguet O, Geier EG, Yokoyama JS, Rissman RA, Rogaeva E, Keith J, Zinman L, Tartaglia MC, Cairns NJ, Cruchaga C, Ghetti B, Kofler J, Lopez OL, Beach TG, Arzberger T, Herms J, Honig LS, Vonsattel JP, Halliday GM, Kwok JB, White CL 3rd, Gearing M, Glass J, Rollinson S, Pickering-Brown S, Rohrer JD, Trojanowski JQ, Van Deerlin V, Bigio EH, Troakes C, Al-Sarraj S, Asmann Y, Miller BL, Graff-Radford NR, Boeve BF, Seeley WW, Mackenzie IRA, van Swieten JC, Dickson DW, Biernacka JM, Rademakers R.

Acta Neuropathol. 2019 Jun;137(6):879-899. doi: 10.1007/s00401-019-01962-9. Epub 2019 Feb 9.

PMID:
30739198
5.

A concise and persistent feature to study brain resting-state network dynamics: Findings from the Alzheimer's Disease Neuroimaging Initiative.

Kuang L, Han X, Chen K, Caselli RJ, Reiman EM, Wang Y; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2019 Mar;40(4):1062-1081. doi: 10.1002/hbm.24383. Epub 2018 Dec 19.

6.

Neuropsychological comparison of incident MCI and prevalent MCI.

Hansen A, Caselli RJ, Schlosser-Covell G, Golafshar MA, Dueck AC, Woodruff BK, Stonnington CM, Geda YE, Locke DEC.

Alzheimers Dement (Amst). 2018 Sep 27;10:599-603. doi: 10.1016/j.dadm.2018.08.009. eCollection 2018.

7.

Age stratification corrects bias in estimated hazard of APOE genotype for Alzheimer's disease.

Liu L, Caselli RJ.

Alzheimers Dement (N Y). 2018 Oct 30;4:602-608. doi: 10.1016/j.trci.2018.09.006. eCollection 2018.

8.

Isometry Invariant Shape Descriptors for Abnormality Detection on Brain Surfaces Affected by Alzheimer's Disease.

Tu Y, Wen C, Zhang W, Wu J, Zhang J, Chen K, Caselli RJ, Reiman EM, Reiman EM, Wang Y.

Conf Proc IEEE Eng Med Biol Soc. 2018 Jul;2018:427-4631. doi: 10.1109/EMBC.2018.8513129.

9.

Brain-Derived Neurotrophic Factor and Its Associations with Metabolism and Physical Activity in a Latino Sample.

Fonseca-Portilla R, Krell-Roesch J, Shaibi GQ, Caselli RJ, Mandarino LJ, Zhang N, Hentz JG, Coletta DK, de Filippis EA, Dawit S, Geda YE.

Metab Syndr Relat Disord. 2019 Mar;17(2):75-80. doi: 10.1089/met.2018.0028. Epub 2018 Nov 10.

10.

APOE ε2 is associated with increased tau pathology in primary tauopathy.

Zhao N, Liu CC, Van Ingelgom AJ, Linares C, Kurti A, Knight JA, Heckman MG, Diehl NN, Shinohara M, Martens YA, Attrebi ON, Petrucelli L, Fryer JD, Wszolek ZK, Graff-Radford NR, Caselli RJ, Sanchez-Contreras MY, Rademakers R, Murray ME, Koga S, Dickson DW, Ross OA, Bu G.

Nat Commun. 2018 Oct 22;9(1):4388. doi: 10.1038/s41467-018-06783-0.

11.

Reply to Comment on "Personality Changes During the Transition from Cognitive Health to Mild Cognitive Impairment".

Caselli RJ, Locke DEC, Woodruff BK, Langlais BT, Dueck AC.

J Am Geriatr Soc. 2019 Jan;67(1):192-193. doi: 10.1111/jgs.15622. Epub 2018 Oct 5. No abstract available.

PMID:
30289960
12.

At the Intersection of Patient Experience Data, Outcomes Research, and Practice: Analysis of HCAHPS Scores in Neurology Patients.

Hanson KT, Zalewski NL, Hocker SE, Caselli RJ, Habermann EB, Thiels CA.

Mayo Clin Proc Innov Qual Outcomes. 2018 May 24;2(2):137-147. doi: 10.1016/j.mayocpiqo.2018.03.007. eCollection 2018 Jun.

13.

Subjective Cognitive Impairment and the Broad Autism Phenotype.

Caselli RJ, Langlais BT, Dueck AC, Locke DEC, Woodruff BK.

Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):284-290. doi: 10.1097/WAD.0000000000000273.

PMID:
30211704
14.

HIPPOCAMPUS MORPHOMETRY STUDY ON PATHOLOGY-CONFIRMED ALZHEIMER'S DISEASE PATIENTS WITH SURFACE MULTIVARIATE MORPHOMETRY STATISTICS.

Wu J, Zhang J, Shi J, Chen K, Caselli RJ, Reiman EM, Wang Y.

Proc IEEE Int Symp Biomed Imaging. 2018 Apr;2018:1555-1559. doi: 10.1109/ISBI.2018.8363870. Epub 2018 May 24.

15.

MULTI-TASK SPARSE SCREENING FOR PREDICTING FUTURE CLINICAL SCORES USING LONGITUDINAL CORTICAL THICKNESS MEASURES.

Zhang J, Tu Y, Li Q, Caselli RJ, Thompson PM, Ye J, Wang Y.

Proc IEEE Int Symp Biomed Imaging. 2018 Apr;2018:1406-1410. doi: 10.1109/ISBI.2018.8363835. Epub 2018 May 24.

16.

Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci.

Sanchez-Contreras MY, Kouri N, Cook CN, Serie DJ, Heckman MG, Finch NA, Caselli RJ, Uitti RJ, Wszolek ZK, Graff-Radford N, Petrucelli L, Wang LS, Schellenberg GD, Dickson DW, Rademakers R, Ross OA.

Mol Neurodegener. 2018 Jul 9;13(1):37. doi: 10.1186/s13024-018-0267-3.

17.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sánchez-Valle R, Antonell A, Lladó A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Öijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R.

Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.

18.

Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.

Stonnington CM, Chen Y, Savage CR, Lee W, Bauer RJ III, Sharieff S, Thiyyagura P, Alexander GE, Caselli RJ, Locke DEC, Reiman EM, Chen K.

J Alzheimers Dis. 2018;63(2):603-615. doi: 10.3233/JAD-170852.

19.

Amyloid-β Increases Tau by Mediating Sirtuin 3 in Alzheimer's Disease.

Yin J, Han P, Song M, Nielsen M, Beach TG, Serrano GE, Liang WS, Caselli RJ, Shi J.

Mol Neurobiol. 2018 Nov;55(11):8592-8601. doi: 10.1007/s12035-018-0977-0. Epub 2018 Mar 24.

PMID:
29574628
20.

Anticholinergic Medications and Cognitive Function in Late Midlife.

Limback-Stokin MM, Krell-Roesch J, Roesler K, Hansen A, Stonnington CM, Temkit M, Caselli RJ, Geda YE.

Alzheimer Dis Assoc Disord. 2018 Jul-Sep;32(3):262-264. doi: 10.1097/WAD.0000000000000251. No abstract available.

Supplemental Content

Loading ...
Support Center